See analyst estimates and all valuation multiples for Medical Supplies
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $190B | 4.4x | 17.5x | |
| $155B | 6.4x | 20.4x | |
| $68.8B | 3.2x | 11.3x | |
| $39.7B | 1.6x | 9.9x | |
| $39.2B | 6.5x | 18.6x | |
| $36.6B | 7.0x | 18.9x | |
| $28.1B | 3.9x | 15.8x | |
| $27.3B | 1.2x | 6.9x | |
| $24.9B | 4.5x | 16.0x | |
| $21.9B | 7.1x | 22.7x | |
| $15.4B | 5.3x | 21.3x | |
| $15.3B | 2.5x | 9.9x | |
| $12.9B | 1.9x | 10.8x | |
| $11.1B | 3.1x | 14.0x | |
| $7.2B | 2.4x | 10.2x | |
| $7.0B | 5.7x | 23.5x | |
| $5.8B | 5.2x | 10.4x | |
| $5.3B | 1.4x | 8.1x | |
| $4.6B | 1.8x | 8.9x | |
| $4.5B | 4.0x | 15.1x | |
| $4.2B | 3.1x | 10.1x | |
| $3.7B | n/a | n/a | |
| $3.6B | 1.8x | 10.8x | |
| $2.8B | 1.4x | 6.4x | |
| $2.8B | 13.7x | 50.6x | |
| $2.1B | 1.9x | 5.4x | |
| $1.6B | n/a | n/a | |
| $1.4B | 1.9x | 7.0x | |
| $1.2B | n/a | n/a | |
| $1.1B | 0.8x | 7.5x | |
| $1.1B | 5.2x | n/a | |
| $1.0B | 11.8x | 58.1x | |
| $953M | n/a | n/a | |
| $812M | n/a | n/a | |
| $661M | 1.0x | 5.0x | |
| $476M | 3.3x | 7.5x | |
| $399M | 3.3x | 36.5x | |
| $362M | 4.7x | 25.1x | |
| $286M | n/a | n/a | |
| $275M | n/a | n/a | |
| $269M | 1.3x | 41.6x | |
| $268M | 9.2x | 50.6x | |
| $264M | n/a | n/a | |
| $231M | n/a | n/a | |
| $217M | 0.8x | 7.2x | |
| $195M | n/a | n/a | |
| $179M | 3.0x | 15.6x | |
| $156M | 0.6x | 2.7x | |
| $133M | n/a | n/a | |
| $83.2M | 1.4x | 7.1x | |
| $45.4M | 0.9x | 12.0x | |
| $42.2M | n/a | n/a | |
| $37.7M | 5.9x | n/a | |
| $28.5M | 0.3x | 14.8x | |
| $26.5M | 14.6x | n/a | |
| $16.8M | n/a | n/a | |
| $15.2M | n/a | n/a | |
| $9.7M | n/a | n/a | |
| $9.3M | n/a | n/a | |
| $8.6M | n/a | n/a | |
| $2.7M | n/a | n/a | |
| $1.5M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| $0.7M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Medical Supplies